Phase II trial of combination pembrolizumab, olaparib, and temozolomide for patients with recurrent glioma

被引：0
|
作者：
Schaff, Lauren [1 ]
Fortunato, John [1 ]
Grommes, Christian [1 ]
Gavrilovic, Igor T. [1 ]
Lin, Andrew [1 ]
Pentsova, Elena [1 ]
Miller, Alex [1 ]
Newton, Adam [1 ]
Gonzalez, Ashley [1 ]
Mellinghoff, Ingo K. [1 ]
Kaley, Thomas Joseph [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS2087
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A Phase II Trial of Temozolomide for Patients with Recurrent or Progressive Brain Metastases
    Lauren E. Abrey
    Jon D. Olson
    Jeffrey J. Raizer
    Michelle Mack
    Ann Rodavitch
    Dina Y. Boutros
    Mark G. Malkin
    Journal of Neuro-Oncology, 2001, 53 : 259 - 265
  • [22] Phase II trial of temozolomide in patients with progressive low-grade glioma
    Quinn, JA
    Reardon, DA
    Friedman, AH
    Rich, JN
    Sampson, JH
    Provenzale, JM
    McLendon, RE
    Gururangan, S
    Bigner, DD
    Herndon, JE
    Avgeropoulos, N
    Finlay, J
    Tourt-Uhlig, S
    Affronti, ML
    Evans, B
    Stafford-Fox, V
    Zaknoen, S
    Friedman, HS
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (04) : 646 - 651
  • [23] Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
    Bower, M
    Newlands, ES
    Bleehen, NM
    Brada, M
    Begent, RJH
    Calvert, H
    Colquhoun, I
    Lewis, P
    Brampton, MH
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (06) : 484 - 488
  • [24] Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
    M. Bower
    E. S. Newlands
    N. M. Bleehen
    M. Brada
    R. J. H. Begent
    H. Calvert
    I. Colquhoun
    P. Lewis
    M. H. Brampton
    Cancer Chemotherapy and Pharmacology, 1997, 40 : 484 - 488
  • [25] Temozolomide in combination with cisplatin in patients with metastatic melanoma: a phase II trial
    Tas, F
    Argon, A
    Camlica, H
    Topuz, E
    MELANOMA RESEARCH, 2005, 15 (06) : 543 - 548
  • [26] One week on/one week off regimen of temozolomide: Phase II trial in recurrent glioma
    Wick, W.
    Wick, A.
    Schuth, J.
    Platten, M.
    Reifenberger, G.
    Weller, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] A PHASE II TRIAL OF SORAFENIB (NEXAVAR) AND PROTRACTED TEMOZOLOMIDE FOR PATIENTS WITH RECURRENT GLIOBLASTOMA
    Reardon, David
    Desjardins, Annick
    Vredenburgh, James
    Friedman, Allan
    Sampson, John
    Gururangan, Sridharan
    Rich, Jeremy
    Friedman, Henry
    NEURO-ONCOLOGY, 2008, 10 (05) : 839 - 839
  • [28] Vorinostat, temozolomide, and bevacizumab for patients with recurrent glioblastoma: A phase I/II trial
    Peters, Katherine B.
    Vredenburgh, James J.
    Desjardins, Annick
    Friedman, Henry S.
    Herndon, James Emmett
    Coan, April D.
    McSherry, Frances
    Lipp, Eric S.
    Brickhouse, Alise
    Massey, Woody C.
    Reardon, David A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
    Quinn, Jennifer A.
    Jiang, Sara Xiaoyin
    Reardon, David A.
    Desjardins, Annick
    Vredenburgh, James J.
    Rich, Jeremy N.
    Gururangan, Sridharan
    Friedman, Allan H.
    Bigner, Darell D.
    Sampson, John H.
    McLendon, Roger E.
    Herndon, James E., II
    Walker, Amy
    Friedman, Henry S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) : 1262 - 1267
  • [30] A phase I/II trial of vandetanib for patients with recurrent malignant glioma
    Kreisl, Teri N.
    McNeill, Katharine A.
    Sul, Joohee
    Iwamoto, Fabio M.
    Shih, Joanna
    Fine, Howard A.
    NEURO-ONCOLOGY, 2012, 14 (12) : 1519 - 1526
12345